VTAK logo

CATHETER PRECISION INC

VTAKNYSE AMERICAN
🏆 #5342 by market capEarnings Nov 12US Equity
$0.15▼ $0.00 (−2.30%)
Latest quote
🔔
Track VTAK
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 2.3%
7d—
14d—
30d▼ 89.6%
ytd▼ 99.1%
1y▼ 99.4%
🏦Market Cap
$312,145
Small Cap
📈Revenue Growth (YoY)
95.0%
High Growth
📊Gross Margin
47.7%
Healthy
💵FCF Margin
-491.8%
Thin
⚖️P/S Ratio
0.2x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$0.15 – $0.15
52-Week Range
$0.15 – $30.60
Volume (shares)
4,588
Avg Volume (shares)
—
Shares Outstanding
2.1M
Next Earnings
2026-11-12

Fundamentals Snapshot

Annual Revenue
$819,000
Last Q Revenue
$1M
P/E Ratio
-0.0
P/S Ratio
0.2x
EPS (TTM)
$-4.58
Dividend Yield
0.00%
Dilution (1yr)
+312.8%
VTAK logo

CATHETER PRECISION INC

VTAK
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$819K▲ +95.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
92.3%▲ +2.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$12M▲ +8.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$8M▼ −11.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.7M▲ +312.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$4M▼ −$5M YoY
StockOtter · stockotter.space

About CATHETER PRECISION INC

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.